Healthcare Bluebook competitors

Mazi Rasulnia is the President and CEO of Pack Health: a leading digital health coaching company that provides personalized education, tools, and support for chronic disease patients. An avid researcher, he has authored more than 85 publications since completing his bachelors of science in Biology at the College of William and Mary. He completed his MPH and MBA at the University of Alabama, Birmingham, where he went on to complete his PhD in health services administration and a fellowship at the Center for Outcomes and Effectiveness Research and Education (COERE). He then began his corporate career at Outcomes Inc, which provides company assessment services in the health education marketplace within the United States and globally. He served as President of Outcomes LLC from 2003, founded M Consulting LLC in 2013, and launched Pack Health in 2014.

Justin Holland is a CEO and Founder at HealthJoy and is based in Chicago, Illinois. He has worked as Co-Founder and CEO at Rakuten Loyalty (formerly FreeCause); Co-Founder, President at OpenInstall, Inc.; and Director at Rakuten Loyalty (formerly FreeCause). Justin works or has worked as First Mate at Even Flow Inc and Co-Founder and CEO at FreeCause.com. He attended Massachusetts Institute of Technology between 2002 and 2006, BERKELEY PREPARATORY SCHOOL, and MIT Sloan between 2002 and 2006.

Mike S. Perry was appointed as Chief Executive Officer (CEO) of AVITA Medical in June 2017, after serving on the Board since February 2013. He brings extensive experience across the global pharmaceutical value chain for healthcare products spanning diverse therapeutic areas, including substantial expertise in cell therapies and cell-based gene therapies. In his career, he has been materially involved in the successful development and commercial launch of over 30 prescription products, 14 of which achieved blockbuster status. Prior to joining AVITA, Dr. Perry’s leadership positions included Chief Scientific Officer of Novartis’ Cell and Gene Therapy Unit from 2014-2017; Vice President and Global Head of Stem Cell Therapy for Novartis Pharmaceuticals Corp. from 2012-2014. With additional positions held as Global Head of R&D at Baxter Healthcare; President and CEO of Cell & Gene Therapy at Novartis affiliates Systemix Inc. and Genetic Therapy, Inc.; Vice President of Regulatory Affairs at Sandoz Pharmaceuticals Corporation; Director of Regulatory Affairs at Schering-Plough Corporation; and Venture Partner with Bay City Capital, LLC, Dr. Perry brings successful global management, guidance and forward direction to AVITA. Since 2011, has served as a Director with Arrowhead Pharmaceutical expanding his reach in influential medical growth.